Get the Stockscreener App
2.08
2.80%
-0.06
After Hours:
2.12
0.04
+1.92%
Dermata Therapeutics Inc stock is traded at $2.08, with a volume of 59,382.
It is down -2.80% in the last 24 hours and down -28.28% over the past month.
Dermata Therapeutics Inc is a late-stage medical dermatology company focused on identifying, developing, and commercializing pharmaceutical product candidates for the treatment of medical skin diseases and aesthetic applications. Its two product candidates, XYNGARI (formerly known as DMT310) and DMT410, incorporate its proprietary, multifaceted, Spongilla technology to topically treat a variety of dermatological conditions. Its Spongilla technology platform will enable to development and formulation of singular and combination products that can target topical delivery of chemical compounds into the dermis for maximum treatment effect for a variety of inflammatory skin diseases. Dermata announced positive Phase 3 data from its STAR-1 clinical trial in March 2025.
See More
Previous Close:
$2.14
Open:
$2.18
24h Volume:
59,382
Relative Volume:
0.07
Market Cap:
$6.65M
Revenue:
-
Net Income/Loss:
$-11.27M
P/E Ratio:
-0.0971
EPS:
-21.4132
Net Cash Flow:
$-9.40M
1W Performance:
-4.59%
1M Performance:
-28.28%
6M Performance:
-67.99%
1Y Performance:
-83.49%
1-Day Range:
$2.05
$2.1899
1-Week Range:
$2.05
$2.43
52-Week Range:
$1.58
$23.70
Dermata Therapeutics Inc Stock (DRMA) Company Profile
Name
Dermata Therapeutics Inc
Sector
Industry
Phone
(858)-223-0882
Address
3525 DEL MAR HEIGHTS RD., #322, SAN DIEGO
Compare DRMA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
DRMA
Dermata Therapeutics Inc
|
2.08 | 6.84M | 0 | -11.27M | -9.40M | -21.41 |
|
VRTX
Vertex Pharmaceuticals Inc
|
463.86 | 119.17B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
796.55 | 84.19B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
398.29 | 52.77B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
788.49 | 48.98B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
175.97 | 36.31B | 447.02M | -1.18B | -906.14M | -6.1812 |
Dermata Therapeutics Inc Stock (DRMA) Latest News
How buybacks impact Dermata Therapeutics Inc. stock value2025 Trade Ideas & Verified Stock Trade Ideas - ulpravda.ru
Can Dermata Therapeutics Inc. Equity Warrant stock deliver consistent earnings growthQuarterly Profit Report & AI Based Trade Execution Alerts - ulpravda.ru
Axillary Hyperhidrosis Market to Evolve Rapidly Over the Next Decade by 2034, DelveInsight Observes | Botanix Pharma, Sound Surgical Tech, Dr. August Wolff GmbH, Medy-Tox, Journey Medical Corp. - Barchart.com
Will Dermata Therapeutics Inc. stock attract more institutional investorsFit and Size Notes & support options for steady strides - ulpravda.ru
Dermata Therapeutics Inc. (DRMA) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
What dividend safety score for Dermata Therapeutics Inc. Equity Warrant stockJuly 2025 Big Picture & Daily Profit Focused Screening - ulpravda.ru
Is Dermata Therapeutics Inc. stock a top pick in earnings seasonMarket Movers & Free Expert Verified Stock Movement Alerts - ulpravda.ru
Why Dermata Therapeutics Inc. Equity Warrant stock is popular among millennialsTrade Exit Summary & Smart Investment Allocation Insights - ulpravda.ru
Is Dermata Therapeutics Inc. stock a contrarian buyJuly 2025 Catalysts & Safe Entry Zone Tips - ulpravda.ru
Is Dermata Therapeutics Inc. stock trading at a premium valuationJuly 2025 Setups & Safe Entry Trade Signal Reports - ulpravda.ru
Aug Ideas: How Dermata Therapeutics Inc. Equity Warrant stock reacts to oil pricesGap Up & Scalable Portfolio Growth Methods - ulpravda.ru
Will Dermata Therapeutics Inc. stock outperform growth indexesWeekly Trade Summary & Real-Time Volume Trigger Notifications - ulpravda.ru
Why Dermata Therapeutics Inc. Equity Warrant stock is a value investor pick2025 Market Trends & Community Consensus Trade Signals - ulpravda.ru
How Dermata Therapeutics Inc. stock benefits from global expansion2025 Biggest Moves & Technical Entry and Exit Tips - ulpravda.ru
Dermata Therapeutics Inc Equity Warrant Stock Analysis and ForecastBullish Engulfing Patterns & Free Phenomenal Capital Appreciation - earlytimes.in
Pre-market Movers: RSLS, STSS, VERO, KTTA... - RTTNews
Dermata Therapeutics announces $2.55M private offering - MSN
Top 5 stocks to watch today | December 30th - MSN
Dermata Therapeutics: Is Change on the Horizon? - StocksToTrade
Dermata Therapeutics: Unveiling Bold Moves - timothysykes.com
Top 5 Stocks To Watch Today | December 30th - MSN
Stock Market Today: S&P 500, Dow Jones Futures Trade Mixed Amid Blip In Santa Claus Rally—Boeing, Freeport-McMoRan, Fonar In Focus - Benzinga
Verastem, TEN Holdings And 3 Stocks To Watch Heading Into Tuesday - Benzinga
Dermata stock surges after closing $4.1 million private placement By Investing.com - Investing.com Australia
Dermata stock surges after closing $4.1 million private placement - Investing.com
Dermata Therapeutics Signs Multiple Material Agreements - TradingView — Track All Markets
Dermata Therapeutics Announces Closing of up to $12.4 Million Private Placement Priced At-The-Market Under Nasdaq Rules - Weatherford Democrat
Skincare firm Dermata raises $4.1M to back new over-the-counter acne kit - Stock Titan
Bank Watch: Why Dermata Therapeutics Inc Equity Warrant stock is popular among millennialsQuarterly Profit Report & High Accuracy Investment Entry Signals - moha.gov.vn
Dermata Therapeutics Announces up to $12.4 Million Private Placement Priced At-The-Market Under Nasdaq Rules - Fox21Online
Dermata Therapeutics, Inc.Warrant (NQ: DRMAW - FinancialContent
Dermata Therapeutics’ Skincare Innovation Sparks Interest - StocksToTrade
Dermata Therapeutics, Inc. (DRMA) Stock: Surges 25% as Insider-Backed $4.1M Offering Fuels Momentum - parameter.io
12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga
Why Is Dermata Therapeutics Stock Surging Wednesday? - Sahm
Why Did Dermata Therapeutics Stock Surge 22% Pre-Market Today? - Menafn.com
Dermata Therapeutics stock soars after securing $4.1 million private placement By Investing.com - Investing.com Nigeria
Dermata Therapeutics stock soars after securing $4.1 million private placement - Investing.com Nigeria
DRMA Stocks Thrive: Time for Action? - timothysykes.com
Why did Dermata Therapeutics stock surge 22% pre-market today? - MSN
Dermata lines up as much as $12.4M to help launch OTC acne kit - Stock Titan
Ingersoll (500210) Stock RalliesVolume Profile Analysis & Investment Recommendations You Can Trust - Bollywood Helpline
Dermata Therapeutics, Inc. announced that it expects to receive $4.124468 million in funding - marketscreener.com
Quarterly Risk: How interest rate cuts could boost ESGRO stockJuly 2025 Market Mood & Free Verified High Yield Trade Plans - Улправда
Dermata Therapeutics Inc Stock (DRMA) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.90%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):